Edge-based FEM-BEM for wide-band electromagnetic computation

Author name used in this publication: S. L. HoAuthor name used in this publication: H. C. Wong2005-2006 > Academic research: refereed > Publication in refereed journalVersion of RecordPublishe

CFP: Cooperative fast protection

Article number: 5062196The 28th Conference on Computer Communications, IEEE INFOCOM 2009, Miniconference, Rio de Janeiro, Brazil, 19-25 April 2009We introduce Cooperative Fast Protection (CFP) as a novel protection scheme in WDM networks. CFP achieves capacity-efficient fast protection with the features of node-autonomy and failure-independency. It differs from p-cycle by reusing the released working capacity of the disrupted lightpaths (i.e. stubs) in a cooperative manner. This is achieved by allowing all the failure-aware nodes to switch the traffic, such that the disrupted lightpaths can be protected even if the end nodes of the failed link are not on the protecting cycles. CFP also differs from FIPP p-cycle by not requiring the source node of the disrupted lightpath on the protecting cycle. By jointly optimizing both working and spare capacity placement, we formulate an ILP for CFP design. Numerical results show that CFP significantly outperforms p-cycle by achieving faster protection with much higher capacity efficiency. © 2009 IEEE.published_or_final_versio

Optical layer monitoring schemes for fast link failure localization in all-optical networks

Optical layer monitoring and fault localization serves as a critical functional module in the control and management of optical networks. An efficient monitoring scheme aims at minimizing not only the hardware cost required for 100{%} link failure localization, but also the number of redundant alarms and monitors such that the network fault management can be simplified as well. In recent years, several optical layer monitoring schemes were reported for fast and efficient link failure localization, including simple, non-simple monitoring cycle (m-cycle) and monitoring trail (m-trail). Optimal ILP (Integer Linear Program) models and heuristics were also proposed with smart design philosophy on flexibly trading off different objectives. This article summarizes those innovative ideas and methodologies with in-depth analysis on their pros and cons. We also provide insights on future research topics in this area, as well as possible ways for extending the new failure localization approaches to other network applications. © 2005 IEEE.published_or_final_versio

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

Post-transplant lymphomas or other lymphoproliferative lesions, which were usually associated with Epstein-Barr virus infections, developed in 8, 4, 3, and 2 recipients, respectively, of cadaveric kidney, liver, heart, and heart-lung homografts. Reduction or discontinuance of immunosuppression caused regression of the lesions, often without subsequent rejection of the grafts. Chemotherapy and irradiation were not valuable. The findings may influence policies about treating other kinds of post-transplantation neoplasms

Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: The role of primary infection

Fourteen patients who developed B cell lymphomas or lymphoproliferative lesions after kidney, liver, heart, or heart-lung transplantation in Pittsburgh during 1981-1983 had active infection with Epstein-Barr virus (EBV)of the primary (six patients), reactivated (seven patients), or chronic (one patient) type. In transplant patients without tumors, the incidence of EBV infection was 30% (39 of 128). Only three of these patients had primary infections. Thus the frequency of active infection was significantly higher in patients with tumors, and patients with primary infections were at greater risk of developing tumors. Five of 13 tumors tested contained EBV nuclear antigen (EBNA) and nine of 11 contained EBV genomes detected by DNA-DNA hybridization with BamHI K, BamHI W, or EcoRI B cloned probes. All EBNA-positive tumors, except one, were also positive by hybridization. Only one tumor was negative for both EBNA and EBV DNA. These data suggest that EBV plays an etiologic role in the development of these lesions. © 1985 by The University of Chicago

Dynamic analysis of linear synchronous machines

Author name used in this publication: S. L. HoAuthor name used in this publication: S. Y. YangAuthor name used in this publication: K. W. E. ChengRefereed conference paper2005-2006 > Academic research: refereed > Refereed conference paperVersion of RecordPublishe

Pneumococcal carriage in sub-Saharan Africa--a systematic review.

BACKGROUND: Pneumococcal epidemiology varies geographically and few data are available from the African continent. We assess pneumococcal carriage from studies conducted in sub-Saharan Africa (sSA) before and after the pneumococcal conjugate vaccine (PCV) era. METHODS: A search for pneumococcal carriage studies published before 2012 was conducted to describe carriage in sSA. The review also describes pneumococcal serotypes and assesses the impact of vaccination on carriage in this region. RESULTS: Fifty-seven studies were included in this review with the majority (40.3%) from South Africa. There was considerable variability in the prevalence of carriage between studies (I-squared statistic = 99%). Carriage was higher in children and decreased with increasing age, 63.2% (95% CI: 55.6-70.8) in children less than 5 years, 42.6% (95% CI: 29.9-55.4) in children 5-15 years and 28.0% (95% CI: 19.0-37.0) in adults older than 15 years. There was no difference in the prevalence of carriage between males and females in 9/11 studies. Serotypes 19F, 6B, 6A, 14 and 23F were the five most common isolates. A meta-analysis of four randomized trials of PCV vaccination in children aged 9-24 months showed that carriage of vaccine type (VT) serotypes decreased with PCV vaccination; however, overall carriage remained the same because of a concomitant increase in non-vaccine type (NVT) serotypes. CONCLUSION: Pneumococcal carriage is generally high in the African continent, particularly in young children. The five most common serotypes in sSA are among the top seven serotypes that cause invasive pneumococcal disease in children globally. These serotypes are covered by the two PCVs recommended for routine childhood immunization by the WHO. The distribution of serotypes found in the nasopharynx is altered by PCV vaccination